Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised,…

By J. San-Miguel, V. Hungria, S. Yoon, M. Beksaç, M. Dimopoulos, A. Elghandour, W. Jędrzejczak, A. Günther, T. N. Nakorn, N. Siritanaratkul and 35 more. The Lancet Oncology, 2014

759 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/a43f2f540f599144fd20e5e20a680f7c50c71af1